Gritstone bio Announces Pricing of $32.5 Million Underwritten Public Offering

April 1, 2024

https://www.globenewswire.com/news-release/2024/04/02/2855616/0/en/Gritstone-bio-Announces-Pricing-of-32-5-Million-Underwritten-Public-Offering.html

EMERYVILLE, Calif., April 01, 2024 (GLOBE NEWSWIRE) — Gritstone bio, Inc. (Nasdaq:GRTS), a clinical-stage biotechnology company working to develop the world’s most potent vaccines, today announced the pricing of an approximately $32.5 million underwritten public offering of its common stock (or pre-funded warrants to purchase common stock in lieu thereof) and accompanying common warrants to purchase common stock (or pre-funded warrants to purchase common stock in lieu thereof), before deducting underwriting discounts and commissions and offering expenses.

Read more at globenewswire.com

NASDAQ and NYSE quotes and data are delayed 15 minutes unless indicated otherwise. Market data and exchange information are provided for informational purposes only and is not intended for trading purposes. Neither 24/7 Market News Editors, 247 Market News, or data and content providers shall be liable for any errors or omissions, delays, misquotes or other market information relayed in any press materials. You should Use Realtime data to conduct due diligence before investing or trading, and trading in any stock is risky you could lose all your money.